ResearcherWenzhou Medical UniversityActive in the last 2 years
Hailun Zheng
Matched on ORCID iD 0000-0001-9842-7931; OpenAlex author ID A5012550213. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 5
- A semi-supervised convolutional neural network for diagnosis of pancreatic ductal adenocarcinoma based on EUS-FNA cytological images. Co-author DOI 10.1186/s12885-025-13910-w↗
- Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment. First author DOI 10.3389/fphar.2021.625084↗
- Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreatic cancer cells. First author DOI 10.1042/bcj20200275↗
- Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. Co-author DOI 10.1002/mc.22951↗
- A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells. Co-author DOI 10.1097/cad.0000000000000470↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ruijie Chen · 2 shared papers, 2020–2021 · strength 0.24
- Paper Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treat… DOI 10.3389/fphar.2021.625084↗
- Paper Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreati… DOI 10.1042/bcj20200275↗
- Longfa Kou · 2 shared papers, 2020–2021 · strength 0.24
- Paper Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treat… DOI 10.3389/fphar.2021.625084↗
- Paper Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreati… DOI 10.1042/bcj20200275↗
- Huanqin Wang · 1 shared paper, 2025 · strength 0.22
- Dong Fang · 1 shared paper, 2025 · strength 0.22
- Guang Liang · 2 shared papers, 2017–2019 · strength 0.15
- Paper Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. DOI 10.1002/mc.22951↗
- Paper A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stres… DOI 10.1097/cad.0000000000000470↗
- Shihui Bao · 1 shared paper, 2021 · strength 0.13
- Yangzom Doma Bhutia · 1 shared paper, 2020 · strength 0.11
- Aimin Cai · 1 shared paper, 2020 · strength 0.11
- Vadivel Ganapathy · 1 shared paper, 2020 · strength 0.11
- Chengguang Zhao · 1 shared paper, 2019 · strength 0.09
- Lehe Yang · 1 shared paper, 2019 · strength 0.09
- Yan Hu · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.